These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38562801)

  • 21. [Neuroimaging in corticobasal syndrome].
    Shinotoh H
    Rinsho Shinkeigaku; 2013; 53(11):1029-32. PubMed ID: 24291869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDG-PET patterns associated with underlying pathology in corticobasal syndrome.
    Pardini M; Huey ED; Spina S; Kreisl WC; Morbelli S; Wassermann EM; Nobili F; Ghetti B; Grafman J
    Neurology; 2019 Mar; 92(10):e1121-e1135. PubMed ID: 30700592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET-based classification of corticobasal syndrome.
    Nakano Y; Shimada H; Shinotoh H; Hirano S; Tagai K; Sano Y; Yamamoto Y; Endo H; Matsuoka K; Takahata K; Kubota M; Takado Y; Kimura Y; Ichise M; Ono M; Sahara N; Kawamura K; Zhang MR; Kuwabara S; Suhara T; Higuchi M
    Parkinsonism Relat Disord; 2022 May; 98():92-98. PubMed ID: 35533530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.
    Whitwell JL; Jack CR; Parisi JE; Gunter JL; Weigand SD; Boeve BF; Ahlskog JE; Petersen RC; Dickson DW; Josephs KA
    Eur J Neurol; 2013 Oct; 20(10):1417-22. PubMed ID: 23746093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterizing the Clinical Features and Atrophy Patterns of
    Young AL; Bocchetta M; Russell LL; Convery RS; Peakman G; Todd E; Cash DM; Greaves CV; van Swieten J; Jiskoot L; Seelaar H; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Sorbi S; Williams SCR; Alexander DC; Rohrer JD;
    Neurology; 2021 Aug; 97(9):e941-e952. PubMed ID: 34158384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropathology and emerging biomarkers in corticobasal syndrome.
    Koga S; Josephs KA; Aiba I; Yoshida M; Dickson DW
    J Neurol Neurosurg Psychiatry; 2022 Jun; 93(9):919-29. PubMed ID: 35697501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease.
    Josephs KA; Whitwell JL; Boeve BF; Knopman DS; Petersen RC; Hu WT; Parisi JE; Dickson DW; Jack CR
    Mov Disord; 2010 Jul; 25(9):1246-52. PubMed ID: 20629131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.
    Brittain C; McCarthy A; Irizarry MC; McDermott D; Biglan K; Höglinger GU; Lorenzl S; Del Ser T; Boxer AL; ; ; ;
    Parkinsonism Relat Disord; 2019 Mar; 60():138-145. PubMed ID: 30201421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
    Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT
    Transl Neurodegener; 2023 Dec; 12(1):57. PubMed ID: 38062485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo retention of
    Smith R; Schöll M; Widner H; van Westen D; Svenningsson P; Hägerström D; Ohlsson T; Jögi J; Nilsson C; Hansson O
    Neurology; 2017 Aug; 89(8):845-853. PubMed ID: 28754841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic and Structural Signatures of Speech and Language Impairment in Corticobasal Syndrome: A Multimodal PET/MRI Study.
    Parmera JB; de Almeida IJ; de Oliveira MCB; Silagi ML; de Godoi Carneiro C; Studart-Neto A; Ono CR; Reis Barbosa E; Nitrini R; Buchpiguel CA; Brucki SMD; Coutinho AM
    Front Neurol; 2021; 12():702052. PubMed ID: 34526958
    [No Abstract]   [Full Text] [Related]  

  • 32. Individual Brain Metabolic Signatures in Corticobasal Syndrome.
    Cerami C; Dodich A; Iannaccone S; Magnani G; Marcone A; Guglielmo P; Vanoli G; Cappa SF; Perani D
    J Alzheimers Dis; 2020; 76(2):517-528. PubMed ID: 32538847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
    Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT
    Res Sq; 2023 Aug; ():. PubMed ID: 37609205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, neuropsychological and imaging characteristics of Alzheimer's disease patients presenting as corticobasal syndrome.
    Constantinides VC; Paraskevas GP; Efthymiopoulou E; Stefanis L; Kapaki E
    J Neurol Sci; 2019 Mar; 398():142-147. PubMed ID: 30711771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological and brain volume differences in patients with left- and right-beginning corticobasal syndrome.
    Jütten K; Pieperhoff P; Südmeyer M; Schleicher A; Ferrea S; Caspers S; Zilles K; Schnitzler A; Amunts K; Lux S
    PLoS One; 2014; 9(10):e110326. PubMed ID: 25357176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
    Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VM; Lee EB; Hansson O
    medRxiv; 2023 Feb; ():. PubMed ID: 36778217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine transporter SPECT imaging in corticobasal syndrome: A peak into the underlying pathology?
    Constantinides VC; Souvatzoglou M; Paraskevas GP; Chalioti M; Boufidou F; Stefanis L; Kapaki E
    Acta Neurol Scand; 2022 Jun; 145(6):762-769. PubMed ID: 35307816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and Trends of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Population-Based Study.
    Stang CD; Turcano P; Mielke MM; Josephs KA; Bower JH; Ahlskog JE; Boeve BF; Martin PR; Upadhyaya SG; Savica R
    J Parkinsons Dis; 2020; 10(1):179-184. PubMed ID: 31594251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Language Disorder in Progressive Supranuclear Palsy and Corticobasal Syndrome: Neural Correlates and Detection by the MLSE Screening Tool.
    Peterson KA; Jones PS; Patel N; Tsvetanov KA; Ingram R; Cappa SF; Lambon Ralph MA; Patterson K; Garrard P; Rowe JB
    Front Aging Neurosci; 2021; 13():675739. PubMed ID: 34381350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.